To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out MoreSyncona Share Price | |
---|---|
Price | 122.00 |
Bid | 121.20 |
Ask | 122.00 |
Change | 1.60 (1.33%) |
Volume | 650,104 |
Open | 121.00 |
High | 122.00 |
Low | 120.40 |
Prev. Close | 120.40 |
Currency | GBX |
---|---|
Issue Country | GG |
Shares in Issue | 652.34m |
Market Capitalisation | £795.85m |
Market Size | 5,000 |
52 Week High | 162.20 |
52 Week High Date | 24-May-2023 |
52 Week Low | 105.00 |
52 Week Low Date | 28-Sep-2023 |
# Trades | 148 |
---|---|
Vol. Sold | 363,446 |
Sold Value | £440.21k |
Vol. Bought | 285,246 |
Bought Value | £347.70k |
PE Ratio | -14.55847 |
Earnings | -8.38 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
07-May-24 | 16:37:04 | 122.00 | 4,697 | Buy* | 121.20 | 122.00 | 5,730 | O Ordinary |
07-May-24 | 16:36:49 | 122.00 | 13,922 | Buy* | 121.20 | 122.00 | 16.98k | O Ordinary |
07-May-24 | 16:35:15 | 122.00 | 63,819 | Buy* | 121.20 | 122.00 | 77.86k | UT Uncrossing Trade |
07-May-24 | 16:27:38 | 121.523 | 1,790 | Sell* | 121.20 | 122.00 | 2,175 | O Ordinary |
07-May-24 | 16:19:12 | 121.64 | 20,000 | Sell* | 121.40 | 122.00 | 24.33k | O Ordinary |
07-May-24 | 16:13:02 | 122.00 | 2,865 | Buy* | 121.40 | 122.00 | 3,495 | A Automatic Execution |
07-May-24 | 15:56:16 | 122.00 | 14 | Buy* | 121.60 | 122.00 | 17.08 | O Ordinary Trade was executed as an SI |
07-May-24 | 15:53:41 | 121.761 | 3,598 | Sell* | 121.60 | 122.00 | 4,381 | O Ordinary |
07-May-24 | 15:53:26 | 121.762 | 10,858 | Sell* | 121.60 | 122.00 | 13.22k | O Ordinary |
07-May-24 | 15:52:41 | 121.648 | 1,344 | Sell* | 121.60 | 122.00 | 1,635 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
09-Mar-22 | 09-Mar-22 | Buy | Robert Hutchinson held the position of Independent Non-Executive Director at the time of this trade.Robert Hutchinson | 171.80 | GBX | 26,000 | 94,827 |
12-May-21 | 11-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 202.05 | GBX | 2,137,172 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 222.12 | GBX | 639,885 | 2,000,000 |
12-May-21 | 10-May-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 223.88 | GBX | 3,222,943 | 2,000,000 |
06-Apr-21 | 01-Apr-21 | Sell | Thomas Henderson held the position of Non-Executive Director at the time of this trade.Thomas Henderson | 250.01 | GBX | 317,961 | 2,000,000 |
We are focused on maximising value at all points of the investment cycle to deliver transformational treatments to patients